Despite the finding that BTP-2 and IGF-I both decreased Orai1 and the TRPC in our LPS-induced ALI mouse injury model, we found no evidence of additive or synergistic effects between these treatments. The gene discussed is IGF1; the disease is acute respiratory distress syndrome.